Pharmaceutical Executive September 25, 2023
Cleve talks about the future of the industry and how data remains a key focus.
New technologies are changing the ways that life sciences and regulatory agencies approach the collection and analysis of data. Scott Cleve, vice president of regulatory operations, information, and compliance at Daiichi Sankyo sat down with Pharm Exec at the Veeva R&D and Quality Summit 2023 in Boston to discuss these topics.
Pharm Exec: What are the current struggles with the regulatory environment right now?
Scott Cleve: For regulatory, we are so focused with understanding the regulations for delivering our products to market and working with FDA. For us, that’s dictated by FDA requirements and guidance, which are more scientific in nature. Those change from time...